Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Alert Fatigue
48%
Aminobisphosphonates
32%
Anion Gap Metabolic Acidosis
64%
Anticholinergic Therapy
32%
Antifibrotic
32%
Clinical Characteristics
32%
Clinical Decision Support Systems
48%
Clinical Outcomes
68%
Clinical Risk
32%
Clinically Significant
42%
Database Performance
32%
Electronic Prescription
42%
Fibroblast Apoptosis
32%
First Year
38%
Formulary
32%
Glycemic Profile
32%
Health Maintenance Organizations
41%
Heart Transplant
32%
Hospitalized Patients
64%
Hypomagnesemia
64%
Incidental
32%
Internal Medicine Wards
40%
Isopentenyl Pyrophosphate
36%
Israel
48%
Lipid Profile
32%
Observational Comparative Studies
32%
Oncology Patients
32%
Papaverine
32%
Pediatric Population
32%
Pharmacokinetics
36%
Pregnancy Outcome
32%
Prescribers
42%
Prescription Errors
40%
Pyroglutamic Acid
64%
Pyroglutamic Acidosis
64%
QT Prolongation
32%
QTc Prolongation
64%
Retrospective Cohort Study
52%
Risk Factors
39%
Serum Magnesium
35%
Suspected Infection
32%
Systemic Sclerosis
64%
T Cells
74%
Tertiary Care Centers
33%
Tertiary Care Hospital
40%
Thiopurines
32%
Voriconazole
64%
Warfarin
33%
Within-individual Variability
32%
Zoledronate
41%
Medicine and Dentistry
Abdominal X-Ray
16%
Acidosis
64%
Anion Gap
64%
Atrial Fibrillation
32%
Bisphosphonate
32%
Bowel Obstruction
16%
Cancer
16%
Cannabinoid
16%
Cesarean Section
16%
Clinical Decision Support System
32%
Clinical Feature
16%
Contrast Medium
16%
Creatinine
17%
Decision Making
16%
Drug Intoxication
16%
Drug Prescription
32%
Electronic Patient Record
20%
Electronic Prescribing
21%
First Trimester Pregnancy
16%
Glycemic
32%
Health Care Cost
42%
Hospital Management
16%
Hypomagnesemia
48%
Illegal Drug
32%
Imatinib
32%
Infection
32%
Infusion
16%
Internal Medicine
32%
Lavage
16%
Lipid
32%
Long QT Syndrome
32%
Magnesium
48%
Medical Imaging
16%
Metabolic Acidosis
64%
Papaverine
32%
Pediatrics
32%
Prognostic Factor
32%
Prospective Cohort Study
32%
Prospective Study
64%
Proton-Pump Inhibitor
32%
Pyroglutamic Acid
64%
QT Prolongation
32%
QTc Interval
20%
Retrospective Cohort Study
40%
Serositis
16%
Tertiary Care
32%
Urinary System
16%
Voriconazole
64%
Watchful Waiting
16%
Zoledronic Acid
32%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Disease
32%
Alkadiene
18%
Antioxidant
18%
Bleeding
16%
Cannabinoid
16%
Carotenoid
32%
Cholinergic Receptor Blocking Agent
32%
Clinical Feature
16%
Cohort Study
100%
Comorbidity
13%
Congenital Malformation
16%
Contrast Medium
16%
Direct Oral Anticoagulant
32%
Drug Intoxication
16%
Drug-Drug Interaction
32%
Electronic Prescribing
64%
Elimination
14%
Etiology
10%
Glucose
21%
Hypomagnesemia
32%
Illegal Drug
32%
Imatinib
32%
Inflammation
32%
Interleukin 6
18%
Intestine Obstruction
16%
Lipid
32%
Long QT Syndrome
32%
Low Birth Weight
16%
Lycopene
32%
Magnesium
16%
Mercaptopurine
32%
Morbid Obesity
32%
Morbidity
16%
Papaverine
32%
Perinatal Death
10%
Pharmacokinetics
36%
Potassium Chloride
32%
Premature Labor
10%
Prospective Study
32%
Proton Pump Inhibitor
32%
QT Prolongation
32%
Retrospective Study
32%
Small for Date Infant
10%
Tacrolimus
32%
Thromboembolism
12%
Triacylglycerol
10%
Trough Level
32%
Upper Gastrointestinal Bleeding
32%
Voriconazole
32%
Warfarin
32%
